AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Sign up Log in

CSL Ltd. Capital/Financing Update 2022

Aug 9, 2022

17854_rns_2022-08-09_bacf2b10-2af0-46de-ab94-e9065ee61931.pdf

Capital/Financing Update

Open in viewer

Opens in your device viewer

==> picture [205 x 32] intentionally omitted <==

==> picture [59 x 30] intentionally omitted <==

==> picture [262 x 27] intentionally omitted <==

For immediate release

10 August 2022

Completion of Vifor Pharma Acquisition

Further to the announcement made on 2 August 2022, CSL Limited (ASX: CSL; USOTC: CSLLY) confirms that its acquisition of Vifor Pharma AG (Vifor), was completed yesterday.

Authorised by Fiona Mead Company Secretary

FURTHER INFORMATION

For further information, please contact: Investors: Steve McKeon Associate Director, Investor Relations CSL Limited Mobile +61 402 231 696 Email: [email protected]